Sensus Healthcare, Inc.
SRTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $7 | $7 | $8 | $13 |
| % Growth | -5.9% | -12.3% | -36.1% | – |
| Cost of Goods Sold | $4 | $4 | $4 | $6 |
| Gross Profit | $3 | $3 | $4 | $7 |
| % Margin | 39.4% | 39.7% | 52.2% | 54.4% |
| R&D Expenses | $2 | $1 | $3 | $2 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $3 | $3 | $4 | $4 |
| Sales & Mktg Exp. | $2 | $1 | $2 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $7 | $5 |
| Operating Income | -$3 | -$2 | -$3 | $2 |
| % Margin | -37.3% | -26.6% | -31.7% | 13.2% |
| Other Income/Exp. Net | $3 | $0 | $0 | $0 |
| Pre-Tax Income | $1 | -$2 | -$2 | $2 |
| Tax Expense | $1 | -$1 | $0 | $0 |
| Net Income | -$1 | -$1 | -$3 | $2 |
| % Margin | -13.7% | -14.2% | -30.8% | 11.8% |
| EPS | -0.058 | -0.064 | -0.16 | 0.095 |
| % Growth | 9% | 60.3% | -269.1% | – |
| EPS Diluted | -0.057 | -0.064 | -0.16 | 0.094 |
| Weighted Avg Shares Out | 16 | 16 | 16 | 16 |
| Weighted Avg Shares Out Dil | 16 | 16 | 16 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | -$2 | -$3 | $2 |
| % Margin | 9% | -24.4% | -30% | 14.2% |